Pfizer to Collaborate with National Cancer Institute to Study Three...
Monday, November 14th 2016 at 1:00pm UTC Cooperative Research and Development Agreement (CRADA) assesses OX40 agonist, utomilumab and avelumab immuno-oncology assets alone and in various combinations...
View ArticleKadmon to Present at the Jefferies 2016 London Healthcare Conference
Monday, November 14th 2016 at 1:30pm UTC NEW YORK–(BUSINESS WIRE)– Kadmon Holdings, Inc. (NYSE:KDMN) today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present an...
View ArticleABMC Reports Third Quarter 2016 Results
Monday, November 14th 2016 at 3:00pm UTC KINDERHOOK, N.Y.–(BUSINESS WIRE)– American Bio Medica Corporation (OTCPK:ABMC) today announced financial results for the three and nine months ended September...
View ArticleFirst Ever Rheumatoid Arthritis Patient Guidelines Announced by CreakyJoints
Monday, November 14th 2016 at 2:30pm UTC CreakyJoints Presents Five Posters at 2016 ACR/AHRP Annual Meeting UPPER NYACK, N.Y.–(BUSINESS WIRE)– CreakyJoints®, the go-to source for more than 100,000...
View ArticleCORRECTING and REPLACING Pfizer Announces Tender Offer for Any and All of its...
Monday, November 14th 2016 at 3:31pm UTC NEW YORK–(BUSINESS WIRE)– Under Information Relating to the Tender Offer, third paragraph, fourth sentence should read: The Tender Offer Documents may be...
View ArticleEOS imaging to Present at the 28th Annual Piper Jaffray Healthcare Conference
Monday, November 14th 2016 at 5:00pm UTC PARIS–(BUSINESS WIRE)– EOS imaging (Euronext, FR0011191766 – EOSI) (Paris:EOSI), the pioneer in 2D/3D orthopedic medical imaging and associated solutions,...
View ArticlePfizer Prices $6,000,000,000 Debt Offering
Monday, November 14th 2016 at 11:55pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) today announced the pricing of a debt offering consisting of five tranches of notes: $1,000,000,000 aggregate...
View ArticlePerkinElmer to Present at Piper Jaffray Healthcare Conference
Monday, November 14th 2016 at 9:15pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company...
View ArticlePfizer Announces Results from Phase 3 OPAL Clinical Development Program...
Tuesday, November 15th 2016 at 1:00pm UTC Detailed Results from Two Phase 3 Studies Featured in Oral & Poster Presentations at 2016 ACR/ARHP Annual Meeting NEW YORK–(BUSINESS WIRE)– Pfizer Inc....
View ArticleFinal Patient Enrolled for Iliofemoral Venous Stent Study
Tuesday, November 15th 2016 at 2:21pm UTC BLOOMINGTON, Ind.–(BUSINESS WIRE)– Cook Medical has completed enrollment in the first clinical study of an iliofemoral venous stent conducted in the United...
View ArticleTeleflex to Present at the 28th Annual Piper Jaffray Healthcare Conference
Wednesday, November 16th 2016 at 11:45am UTC WAYNE, Pa.–(BUSINESS WIRE)– Benson F. Smith, Chairman and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 28th Annual Piper Jaffray...
View ArticleCellectis Announces Successful cGMP Manufacturing for Second Product...
Tuesday, November 15th 2016 at 10:00pm UTC NEW YORK–(BUSINESS WIRE)– Regulatory News: Cellectis (Paris:ALCLS) (NASDAQ:CLLS) (Alternext: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on...
View ArticlePiper Jaffray to Host 28th Annual Healthcare Conference
Tuesday, November 15th 2016 at 7:25pm UTC NEW YORK–(BUSINESS WIRE)– Piper Jaffray Companies (NYSE: PJC), a leading investment bank and asset management firm, will host its 28th annual Healthcare...
View ArticleBristol-Myers Squibb and Enterome Announce Immuno-Oncology Collaboration...
Wednesday, November 16th 2016 at 8:00am UTC NEW YORK & PARIS–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) and Enterome, a pioneer in the development of pharmaceuticals and diagnostics...
View ArticleGilead Sciences to Present at the Annual Piper Jaffray Healthcare Conference...
Tuesday, November 15th 2016 at 10:00pm UTC Webcast Available Through Gilead Corporate Website FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John F....
View ArticleReplicor Discloses Late Breaking HBV and Follow-Up HBV / HDV Clinical Data at...
Tuesday, November 15th 2016 at 2:58pm UTC MONTREAL–(BUSINESS WIRE)– Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic hepatitis B and D patients, today presented...
View ArticleGenexine Enters into Clinical Research Collaboration with MSD
Wednesday, November 16th 2016 at 1:00pm UTC SEONGNAM, South Korea–(BUSINESS WIRE)– Genexine (KOSDAQ:095700), a clinical stage biotechnology company developing innovative biologics, today announced...
View ArticleMedidata Honors Chiltern with Inaugural Architect of Hope Award, Celebrating...
Wednesday, November 16th 2016 at 1:30pm UTC NEW YORK–(BUSINESS WIRE)– Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, is pleased to...
View ArticleGenexine Granted FDA Orphan Drug Designation for GX-H9 in Growth Hormone...
Wednesday, November 16th 2016 at 1:00pm UTC SEONGNAM, South Korea–(BUSINESS WIRE)– Genexine (KOSDAQ: 095700), an innovative biotechnology company focused on immuno-oncology, metabolic and orphan...
View ArticlePALOMA-2 Phase 3 Study Published In The New England Journal Of Medicine...
Wednesday, November 16th 2016 at 10:09pm UTC First-in-class IBRANCE in Combination with Letrozole Exceeded 2 Years in Median PFS NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) today announced that...
View Article